1. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. (10th January 2023) Authors: Unger, Joseph M; Qian, Lu; Redman, Mary W; Tavernier, Susan S; Minasian, Lori; Sigal, Ellen V; Papadimitrakopoulou, Vassiliki A; Leblanc, Michael; Cleeland, Charles S; Dzingle, Samuel A; Summers, Thomas J; Chao, Herta; Madhusudhana, Sheshadri; Villaruz, Liza; Crawford, Jeffrey; Gray, Jhanelle E; ... Journal: Journal of the National Cancer Institute Issue: Volume 115:Number 4(2023) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗